March 11th 2008

"Brachytherapy for Prostate Cancer:
Who should consider it and why"

Dr. Juanita M Crook, FRCPC, MD

Professor of Radiation Oncology
University of Toronto
Princess Margaret Hospital

An audience of around 45 members, wives attended this very informative
talk by Dr. Juanita Crook.

Dr. Juanita Crook's talk dealt with the very interesting subject of brachytherapy,
who should be considering it and why. She described how data such as the PSa,
gleason score and staging etc. was used to decide the risk groups and to determine
the best treatment options for a given patient. She went into details of the selection
factors for brachytherapy discussing the quality of life issues related to how
brachytherapy compared with various other treatments options. Her talk covered
the type of radiation used in brahytherapy, the types of seeds used, their half life,
their implantation techniques and and how they worked.

Dr. Crook explained that brachytherapy had been around since the late 1980s and
went on to present long term outcomes comparing the results with the other treatments,
the effect of age and some of the side effects and how they were managed. She also
covered several FAQs touching amongst others areas such PSa kinetics,
radiation safety and PSa 'bounce' following brachytherapy. The talk concluded with
a summary of key Brachyterapy advantages and side effects.

The talk was easily understood and highly appreciated by audience - the presentation
slides being rich in graphics, X-ray images and graphical data together with Dr. Crook's
crisp and easy to follow explanations.

Following the talk Dr. Crook responding to a host of interesting questions
from the audience during the Questions and Answer session.

We are pleased to offer Audio and Presentation slide
downloads of this session - please follow the links provided further down.

About Dr. Juanita Crook

Dr. Crook is the Head of the PMH/UHN prostate brachytherapy program. Over 900 men have been
treated in this program since it was established in March 1999. Dr. Crook was one of the Canadian
pioneers on the use of intermittent androgen suppression for recurrent or metastatic prostate
cancer, establishing a Phase 2 trial in Ottawa in 1993. She has published 2 book chapters and 2 articles
on the use of brachytherapy for penile cancer and is a world-renowned authority on this subject.

Our thanks to Dr. Juanita Crook for a
an excellent and informative presentation.

AUDIO & SLIDES DOWNLOADS

AUDIO:

NO AUDIO AVAILABLE

SLIDES:

Brachytherapy Slides